Continuing Legal Education Credits (CLE)
Hofstra Law School is an accredited New York State CLE Provider. New York CLE credits are available to satisfy the mandatory requirement, non- transitional, area of professional practice, for attorneys attending the conference. Please advise the CLE service secretary at the registration desk if you wish CLE credit. The program consists of two sessions: Session I (March 5), 7.5 credits; and Session II (March 6) 8.5 credits. Credit will be given for each session. No credit can be given for partial attendance at a session. Lawyers admitted in jurisdictions other than New York should check with those jurisdictions to determine CLE requirements in their states. Scholarships are available; to apply for a scholarship, contact Dawn Marzella at (516) 463-6889.
Continuing Medical Education Credits (CME)
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of North Shore-LIJ Health System and Hofstra Law School. North Shore-LIJ Health System is accredited by the Accreditation Council for Continuing Medical Education to provide Continuing Medical Education for physicians.
North Shore-LIJ Health System designates this educational activity for a maximum of 14 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy
North Shore-LIJ Health System adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by North Shore-LIJ for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.
Goals and Objectives
All North Shore-LIJ Health System CME activities are designed to lead to improved patient care and patient safety. At the conclusion of this activity, participants should be able to:
- Better evaluate the potential of human embryonic stem cell research in the advancement of biomedical research and patient care.
- Better evaluate the societal and ethical concerns about the research.
- Better evaluate the effect of policy and law on the research.
- Better evaluate the level of legal and financial uncertainty regarding the research.


